Shanghai Pharmaceuticals Holding Co. Ltd.
601607Pharmaceuticals
CN¥16.43−0.18%As of Oct 29vs prior close
- Market cap
- $6.9B
- P/E (TTM)
- 12.7×
- P/E (FY1)
- 10.4×
- From 52W high
- −10.76%
- EPS (LTM)
- CN¥1.29
- Revenue (LTM)
- CN¥289.5B
- Net margin
- 1.65%
Nomior Score
45
Patient ValueBottom 38% of the scored universe
Growth45
Quality45
Value72
Momentum16
Resilience62
Growth
+6.92%revenue a year over 3 fiscal years
YE22 CN¥232BLTM CN¥289.5B
Connections
Revenue to profitYE25
2% of revenue became net profit.